
Publication
The outlook for M&A after the US elections
This update discusses M&A opportunities after exploring the pandemic-related challenges to be overcome in M&A dealmaking.
The impact of COVID-19, including its wide-ranging effect on “business-as-usual” activities, raises a number of issues for companies. Listed companies are having to consider their ongoing disclosure obligations and how to hold shareholder meetings, and all companies are reviewing the implications of the coronavirus for their financial position and performance, as well as their financial arrangements.
Directors need to be mindful of their duties to employees, shareholders and other stakeholders and, in the context of transactions, deal timetables are being impacted and termination rights and logistics reviewed. Companies are also undertaking supply chain diligence and reviewing contractual terms as part of the identification of potential areas of legal or regulatory risk.
Publication
This update discusses M&A opportunities after exploring the pandemic-related challenges to be overcome in M&A dealmaking.
Publication
While there is little doubt that the immediate impact of the COVID-19 pandemic has suppressed public M&A activity over the last few months, opportunities for investment in listed assets and the potential benefits of corporate consolidation and/or bolt on M&A arising from the uncertainty are likely to drive takeover activity in the second half of the year.
Publication
Parties to M&A agreements are grappling with increased risk and uncertainty in light of the COVID-19 pandemic.
Publication
The COVID-19 pandemic has resulted in unprecedented challenges for businesses in all sectors, coupled with market upheaval and volatile share prices.
Publication
This briefing looks at some of the challenges for existing corporate joint ventures as well as the key issues to be considered when entering into new joint venture arrangements whilst the continuing effects of the COVID-19 pandemic are felt and in the depressed market conditions which are likely to persist for the short to medium term.
Publication
COVID-19 has gone far beyond creating a temporary crisis.
Publication
Until recently, the so-called Opec+ arrangement had successfully managed supply to keep the oil price up in the face of a global slow-down in demand, but within a matter of months all that has changed.
Publication
In this Briefing we consider some of the areas of a privately negotiated M&A transaction which may be affected by the continuing effects of the COVID-19 pandemic.
Update
As a result of the COVID-19 outbreak, many businesses find themselves confronted with a potentially significant decrease in turnover without a clear indication of when this crisis will be resolved. Consequently, companies are trying to limit their costs in these difficult times.
Publication
On April 8, 2020 the Financial Conduct Authority (FCA) announced a package of measures intended to assist companies to raise new share capital in response to the coronavirus crisis, whilst retaining an appropriate degree of investor protection.
Publication
2020 has already seen a significant uptick in preemptive standard and NOL pill adoption.
Publication
The following guide brings together summaries of the top legal concerns for the remainder of 2020 for insurers from a number of different regions.
Update
The recent measures introduced across Europe to deal with the COVID-19 pandemic have led to volatility in the public equity markets which exceed even that of the global financial crisis in 2008/9
Publication
As COVID-19 continues, companies engaged in M&A transactions must overcome increased risk and uncertainties.
Publication
The COVID-19 pandemic raises a range of issues for companies in all sectors, including the ability to access the finance necessary to maintain business operations during these challenging times.
Publication
Essential goods and services suppliers face unprecedented demand in an environment where exceptional safety measures need to be taken.
Publication
COVID-19’s impact on the economy is leading to liquidity concerns for many Canadian businesses.
Publication
In our briefing COVID-19: What does this mean for AGMs?, we considered a number of issues with which companies with December 31 year-ends have been grappling.
Publication
The CARES Act contains a number of tax provisions intended to provide relief for individuals, families, and businesses facing the COVID-19 pandemic.
Publication
To manage the economic impacts of the COVID-19 pandemic, the US government has enacted new legislation to provide emergency funding for businesses.
Publication
While capital markets rely on companies to provide timely and accurate information, and investors, shareholders and others rely on companies to provide financial reports that have been through a rigorous audit process, government and regulators in the UK recognise that the COVID-19 pandemic is creating huge challenges for both corporate reporting and audit processes.
Publication
The EPA will apply enforcement discretion for noncompliance: (i) during the period of the policy; (ii) that results from the COVID-19 pandemic.
Update
COVID-19 is having far reaching impacts on the construction industry’s supply chains, cash flows and workforces.
Publication
Parties should cautiously utilize "general notices" of force majeure in construction contracts.
Publication
This update explores using electronic signatures under New York law and identifies important considerations when engaging in complex transactions.
Publication
What public companies should consider amid falling energy prices and SEC disclosure and risk mitigation.
Update
The COVID-19 pandemic is having wide ranging and deep effects on companies in all sectors. In this context, publicly traded companies need to consider their ongoing disclosure obligations.
Publication
In response to the mounting as COVID-19 (coronavirus) crisis, the CSA announced it will provide blanket relief from certain regulatory filings required to be filed on or before June 1, 2020.
Update
In light of the coronavirus outbreak, this update provides recommendations for US boards to comply with risk oversight.
Update
The COVID-19 (coronavirus) pandemic is having wide ranging and deep effects on the “business as usual” activities of all corporates. In this briefing, we focus on some examples of high-level legal considerations which the COVID-19 outbreak may drive.
Update
The COVID-19 pandemic poses immediate current and future challenges for UK businesses.
Subscribe and stay up to date with the latest legal news, information and events...
© Norton Rose Fulbright LLP 2020